Table 3

Correlations between peak TnT, AUCs of TnT and neutrophil cell count, and NETs markers the first 3 days after randomisation

	Peak TnT
	Total population		Placebo (n=59)		Tocilizumab (n=58)
	r	P value	r	P value	r	P value
H3Cit AUC	0.043	0.693	−0.073	0.632	0.097	0.551
dsDNA AUC	0.35	0.001	0.444	0.002	0.226	0.161
MPO–DNA AUC	−0.166	0.134	−0.181	0.239	−0.191	0.243
	TnT AUC
H3Cit AUC	0.105	0.261	0.136	0.304	0.195	0.143
dsDNA AUC	0.412	<0.0001	0.528	<0.0001	0.309	0.018
MPO–DNA AUC	−0.128	0.172	−0.159	0.234	−0.045	0.737
	Neutrophil AUC
H3Cit AUC	−0.226	0.015	0.203	0.123	0.023	0.865
dsDNA AUC	0.145	0.120	0.333	0.010	0.020	0.883
MPO–DNA AUC	0.013	0.887	0.023	0.862	0.128	0.345

Significant values are marked in bold.
AUC, area under the curve; dsDNA, double-stranded DNA; H3Cit, citrullinated histone 3; MPO–DNA, myeloperoxidase–DNA; NETs, neutrophil extracellular traps; TnT, troponin T.